Benzinga | Aug 5, 2020 04:49PM EDT

Harpoon Therapeutics Q2 EPS $(0.51) Down From $(0.49) YoY, Sales $2.76M Up From $1.06M YoY

Harpoon Therapeutics (NASDAQ:HARP) reported quarterly losses of $(0.51) per share. This is a 4.08 percent decrease over losses of $(0.49) per share from the same period last year. The company reported $2.76 million in sales this quarter. This is a 159.83 percent increase over sales of $1.06 million the same period last year.